# Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)

> **NCT05410652** · — · COMPLETED · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 1176 (actual)

## Conditions studied

- Helicobacter Pylori Infection
- Helicobacter Pylori gyrA Levofloxacin Resistance Mutation
- Fecal Drug Resistance Gene Detection
- Helicobacter Pylori Infection, Susceptibility to

## Interventions

- **DIAGNOSTIC_TEST:** Detection of fecal samples with diagnostic kit
- **DIAGNOSTIC_TEST:** Sanger Sequencing group
- **DIAGNOSTIC_TEST:** Bacterial culture and drug sensitivity test of gastric mucosa samples

## Key facts

- **NCT ID:** NCT05410652
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2023-09-12
- **Final completion:** 2023-10-01
- **Target enrollment:** 1176 (ACTUAL)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05410652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05410652, "Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05410652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*